StockUnited StatesNasdaqGS

TXG

10x Genomics, Inc.

Healthcare · Medical Devices

67.29USD

+1.6900 (+2.58%)

Description Historical Financials Relative Value Research News Discussion OptionsPrice Chart ↗Fundamental Chart ↗

Fiscal Year End12/2025

Last Quarter End06/2026 Q2

Current/T12M(USD)

Issue Data

Last PxUSD / 67.29

P/E—

Dvd Ind Yld—

P/B10.62

P/S14.2

Curr EV/T12M EBITDA-201.3

Mkt Cap (USD)8.8B

Curr EV (USD)8.3B

Per Share Data

EPS T12M-0.59

DPS—

Bk Val Per Sh6.31

Rev/Sh4.75

Cash/Sh4.24

Curr Shares Out120.2M

FCF/Sh0.93

Cash Flow Analysis

P/CF69.0

Curr P/FCF72.2

CF/NI-1.7

Dvd P/O0.0%

Cash Gen/Cash Reqd—

Csh Dvd Cov—

CFO/Sales20.6%

Eff Interest Rate0.0%

Growth Potential

Dil EPS 1Y Gr77.0%

Cap 1Y Gr12.1%

BPS 1Y Gr8.3%

R&D To Sales—

Retention Rate100.0%

Rev 1Y Gr5.2%

FCF 1Y Gr2371.2%

Assets 1Y Gr13.4%

Profitability

EBITDA-0.0B

EBIT-0.1B

Operating Margin-14.3%

Pretax Margin-12.1%

Net Margin-12.2%

ROA-7.5%

ROE-9.4%

ROC—

Asset Turnover0.61

Structure

Current Ratio5.69

Quick Ratio5.09

Debt/Assets0.0%

Debt/Com Eq0.0%

Net Debt/EBITDA7.11

Tot Debt/Capital0.0%

Gross Margin70.0%

EBIT/Int Exp—

Returns and turnover use the AVERAGE balance over the year, not the closing snapshot. Growth rates compare the two most recent fiscal years.

Reading financial statements from SEC filings…

A first visit to a security takes a few seconds.